BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 20433999)

  • 1. Thromboprophylaxis during chemotherapy in patients with advanced cancer.
    Agnelli G; Verso M
    Thromb Res; 2010 Apr; 125 Suppl 2():S17-20. PubMed ID: 20433999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thromboprophylaxis during chemotherapy after advanced cancer.
    Agnelli G; Verso M
    Thromb Res; 2007; 120 Suppl 2():S128-32. PubMed ID: 18023706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer.
    Agnelli G; George DJ; Kakkar AK; Fisher W; Lassen MR; Mismetti P; Mouret P; Chaudhari U; Lawson F; Turpie AG;
    N Engl J Med; 2012 Feb; 366(7):601-9. PubMed ID: 22335737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study.
    Agnelli G; Gussoni G; Bianchini C; Verso M; Mandalà M; Cavanna L; Barni S; Labianca R; Buzzi F; Scambia G; Passalacqua R; Ricci S; Gasparini G; Lorusso V; Bonizzoni E; Tonato M;
    Lancet Oncol; 2009 Oct; 10(10):943-9. PubMed ID: 19726226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous thromboembolism and cancer: a two-way clinical association.
    Agnelli G
    Thromb Haemost; 1997 Jul; 78(1):117-20. PubMed ID: 9198139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of venous thromboembolism in the cancer surgical patient.
    Kakkar AK
    J Clin Oncol; 2009 Oct; 27(29):4881-4. PubMed ID: 19738112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk stratification and venous thromboprophylaxis in hospitalized medical and cancer patients.
    Prandoni P; Samama MM
    Br J Haematol; 2008 May; 141(5):587-97. PubMed ID: 18422787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cancer and venous thromboembolism].
    Meyer G; Belmont L
    Rev Mal Respir; 2011 Apr; 28(4):443-52. PubMed ID: 21549900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of evidence to support thromboprophylaxis in hospitalized medical patients with cancer.
    Carrier M; Khorana AA; Moretto P; Le Gal G; Karp R; Zwicker JI
    Am J Med; 2014 Jan; 127(1):82-6.e1. PubMed ID: 24384102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of venous thromboembolism in cancer patients.
    Kakkar AK; Williamson RC
    Semin Thromb Hemost; 1999; 25(2):239-43. PubMed ID: 10357091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
    Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
    Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
    van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
    Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective evaluation of venous thromboembolism prophylaxis in the adult cancer population.
    Reeves D; Liu CY
    J Oncol Pharm Pract; 2010 Mar; 16(1):27-31. PubMed ID: 19401307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Venous thromboembolism prophylaxis in internal medicine].
    Malý J; Widimský J; Dulícek P
    Vnitr Lek; 2009 Mar; 55(3):190-5. PubMed ID: 19378845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing cancer-related venous thromboembolic disease: low-molecular-weight heparins and beyond.
    O'Connell CL; Liebman HA
    Expert Rev Hematol; 2008 Dec; 1(2):175-82. PubMed ID: 21082922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
    Huo MH; Muntz J
    Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of thrombotic disorders in cancer patients undergoing chemotherapy.
    Levine MN
    Thromb Haemost; 1997 Jul; 78(1):133-6. PubMed ID: 9198142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and risk factors of venous thromboembolic events in lymphoma.
    Zhou X; Teegala S; Huen A; Ji Y; Fayad L; Hagemeister FB; Gladish G; Vadhan-Raj S
    Am J Med; 2010 Oct; 123(10):935-41. PubMed ID: 20920696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rationalization of risk factors for venous thromboembolism in medical inpatients. A prospective study].
    Pottier P; Planchon B; Truchaud F; Pistorius MA; Furic I; Grolleau JY
    J Mal Vasc; 2000 Oct; 25(4):241-9. PubMed ID: 11060418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of deep vein thrombosis in cancer patients.
    Lee AY
    Semin Thromb Hemost; 2007 Oct; 33(7):699-706. PubMed ID: 18000798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.